We are excited to announce that lab member Maria Luise da Costa Zemsch was recently on the Podcast zu Langlebigkeit! The topic of the podcast was ketamine as an antidepressant – a topic at the core of Luise's research at Berlin Institute of Health at Charité - Universitätsmedizin Berlin.
The podcast explored:- The limitations of conventional antidepressants- Biological/psychological roots of depression- Gender differences in treatment response or better… why research lags (#GenderDataGap)- Ketamine’s brain mechanisms and neuroplasticity- How psychedelic-assisted psychotherapy could redefine mental healthcare
𝐖𝐡𝐲 𝐓𝐡𝐢𝐬 𝐌𝐚𝐭𝐭𝐞𝐫𝐬
Ketamine—and psychedelics more broadly—represent a paradigm shift in treating mental health conditions. Their potential for rapid and lasting relief offers new hope, especially when other treatments fail.
Luise's 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐌𝐢𝐬𝐬𝐢𝐨𝐧
Using #ComputationalNeuroscience to decode why this works:- Applying #MachineLearning within a network neuroscience framework to longitudinal connectome data to uncover the neural correlates of therapeutic response- Understanding the #mechanisms behind Ketamine’s (and other fast-acting therapies) fast-acting antidepressant effects- Prioritizing gender-specific responses as an important step for #PersonalizedMedicine- Future: Multiscale simulations (e.g. #TheVirtualBrain) to predict patient-specific outcomes
🎧 Listen to the podcast here: Podcast zu Langlebigkeit
